Clear.
Concise.
Accessible.
Quick, brand reinforcing and marketing-type information can be place in this module.
Administrators will be able to select which modules appear on the main page, and the administrator will be able to determine where the module will be placed on the page.
- FDA Issues Complete Response Letter to VIVUS Regarding New Drug Application for QNEXA® - 3 hours ago
- Forty-One Leading Physicians in Castle Connolly's New America's Top Doctors(R) for Cancer 6th Edition are Named as Grant Recipients at Breast Cancer Research Foundation Awards Luncheon - 5 hours ago
- The Ensign Group Reports Record Third Quarter - 5 hours ago
- The Academy of General Dentistry (AGD) Cautions Against Misuse of Kellogg Foundation's Evaluation of Dental Health Aide Therapists - 5 hours ago
- Pfizer's Lyrica® (Pregabalin) Capsules CV Receives Approval for Treatment of Peripheral Neuropathic Pain In Japan - 6 hours ago
- Healthcare Trust of America, Inc. Executes Agreement to Acquire an Approximately 960,000 Square Foot Multi-State Medical Office Building Portfolio - 6 hours ago
- Pfizer Declares an 18-Cent Fourth-Quarter 2010 Dividend - 6 hours ago
- 2010-2011 Influenza Documents (5)
- Alerts (3)
- Ambulatory Care Pharmacy Services (18)
- Antimicrobial Information (9)
- Board/Regulatory Information (8)
- Clinical Trials (3)
- Current Pharmacy Newsletters (2)
- Health Care Links (17)
- Inpatient Pharmacy Contacts (1)
- Investigational Drug Services (4)
- Kaizen Bulletins (17)
- Medication Information (4)
- Medication Policies and Guidelines (20)
- Medication Safety (44)
- Medication Storage Checklist (5)
- P&T Recent Actions (3)
- Pharmacy Tools (8)
- Quick Links (4)
- Vaccine Information (17)